Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3497070rdf:typepubmed:Citationlld:pubmed
pubmed-article:3497070lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C0008356lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C0036536lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C0036537lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C0021853lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C0521378lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:3497070lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:3497070pubmed:issue3lld:pubmed
pubmed-article:3497070pubmed:dateCreated1987-9-9lld:pubmed
pubmed-article:3497070pubmed:abstractTextThis study was designed to investigate the location, specificity, and significance of antibody-containing cells in the liver. After intestinal administration of cholera toxin, high numbers of specific antibody-containing cells appeared in the liver during the early priming period and after boosting. In contrast, a significant number of specific antibody-containing cells appeared in the lamina propria of the intestine only after boosting. In the liver, the specific antibody-containing cells were predominantly located in the sinusoidal region of zone 1 of the liver lobules. About 80% of the specific antibody-producing cells in the liver synthesized anticholera toxin antibody of the immunoglobulin A class. During the priming period, the concentration of immunoglobulin A anticholera toxin in bile paralleled the increase and decrease in the number of specific antibody-containing cells in the liver. Liver perfusion experiments indicated that during the priming period at least 70% of the biliary immunoglobulin A anticholera toxin antibody was synthesized within the liver, whereas 30% was synthesized in the liver after boosting. Thus, during the early immune response, the liver seems to be the major source for specific biliary antibody to intestinally administered cholera toxin.lld:pubmed
pubmed-article:3497070pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3497070pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3497070pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3497070pubmed:languageenglld:pubmed
pubmed-article:3497070pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3497070pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3497070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3497070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3497070pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3497070pubmed:statusMEDLINElld:pubmed
pubmed-article:3497070pubmed:monthSeplld:pubmed
pubmed-article:3497070pubmed:issn0016-5085lld:pubmed
pubmed-article:3497070pubmed:authorpubmed-author:JonesA LALlld:pubmed
pubmed-article:3497070pubmed:authorpubmed-author:ScottJ HJHlld:pubmed
pubmed-article:3497070pubmed:authorpubmed-author:AltorferJJlld:pubmed
pubmed-article:3497070pubmed:authorpubmed-author:HardestyS JSJlld:pubmed
pubmed-article:3497070pubmed:issnTypePrintlld:pubmed
pubmed-article:3497070pubmed:volume93lld:pubmed
pubmed-article:3497070pubmed:ownerNLMlld:pubmed
pubmed-article:3497070pubmed:authorsCompleteYlld:pubmed
pubmed-article:3497070pubmed:pagination539-49lld:pubmed
pubmed-article:3497070pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:meshHeadingpubmed-meshheading:3497070-...lld:pubmed
pubmed-article:3497070pubmed:year1987lld:pubmed
pubmed-article:3497070pubmed:articleTitleSpecific antibody synthesis and biliary secretion by the rat liver after intestinal immunization with cholera toxin.lld:pubmed
pubmed-article:3497070pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3497070pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3497070pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:3497070pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3497070lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3497070lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3497070lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3497070lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3497070lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3497070lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3497070lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3497070lld:pubmed